Cite
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
MLA
Francesca Bosco, et al. “Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence.” International Journal of Molecular Sciences, vol. 24, no. 16, Aug. 2023, p. 12639. EBSCOhost, https://doi.org/10.3390/ijms241612639.
APA
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, Ernesto Palma, Rita Citraro, Maria Tiziana Corasaniti, Antonio Leo, & Giovambattista De Sarro. (2023). Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence. International Journal of Molecular Sciences, 24(16), 12639. https://doi.org/10.3390/ijms241612639
Chicago
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, Ernesto Palma, Rita Citraro, Maria Tiziana Corasaniti, Antonio Leo, and Giovambattista De Sarro. 2023. “Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence.” International Journal of Molecular Sciences 24 (16): 12639. doi:10.3390/ijms241612639.